Toxoplasma IgM
Toxoplasmosis is a disease caused by the parasite Toxoplasma gondii. Toxoplasma gondii is an obligate intracellular protozoan that causes human infection via ingestion, transplacental transfer, blood products, or organ transplantation. Cats are the definitive hosts of T. gondii and pass oocysts in their feces. Human are intermediate hosts and infection occurs through ingestion of sporulated oocysts from undercooked meats or from ingestion of food or water contaminated with cat feces. Fetuses acquire the infection via the transplacental route.
Serological testing is important in diagnosing toxoplasmosis because culture of the T. gondii organism is difficult, and most laboratories are not equipped to culture the organism. Testing is also available on most immunoassay platforms. Testing consists of either IgG or IgM antibodies. It is estimated that more than 60 million people in the United States are infected with T. gondii organism. In most normal adults, infections are asymptomatic. In those with clinical syptoms, the most common is lymphadenopathy, which may be accompanied by various other nonspecific symptoms. The greatest concern is in those who are immunocompromised, or the fetus of a previously uninfected mother, because the organism is capable of crossing the placenta. Infection during pregnancy may result in the child being blind, having mild to severe CNS damage, or death. Women who are exposed to the parasite before pregnancy do not transmit the parasite to the fetus. However, if infected during the pregnancy it can be transfered to the fetus. Most infections in immunocompromised patients are thought to be due to reactivation of latent infection, and many involve the central nervous system. The severity of congenital infection in utero declines as the pregnancy progresses. The majority of infants infected in utero show no symp.
- Diagnosis of toxoplasmosis
- Differential diagnosis of acute, recent, or reactivated toxoplasma infection
- Differential diagnosis of acute congenital toxoplasmosis
- To determine (IgM) recent serological response to toxoplamsa
Increased/Positive in:
- Toxoplasma gondii infection (acute, recent, or reactivation)
- Acute or congenital toxoplasmosis (IgM)
- Acute, recent or reactivated toxoplasma infection (IgG and IgG)
Depending on the methodology, results could be reported qualitative as Negative, or semi-quantitative index value. A cutoff of 1.0 Index Value is used to distinguish positive from negative samples:
- Samples with a calculated value of less than 0.9 Index are considered negative
- Samples with a calculated value between 0.9 and 0.99 Index are considered equivocal
- Samples with a calculated value greater than or equal to 1.0 Index are considered positive
Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).
Serum (SST).
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 30 days
CSF
Stability
- Ambient: 48 hours
- Refrigerated: 14 days
- Frozen: 60 days
- Clin Lab Med. 1991 Dec;11(4):923-39. [PMID: 1802529]
- Am J Med. 2005 Mar;118(3):212-6. [PMID: 15745715]
- Trends Parasitol. 2010 Apr;26(4):190-6. [PMID: 20202907]
- Pediatr Infect Dis J. 1997 Dec;16(12):1166-75. [PMID: 9427464]
- Int J Parasitol. 2008 Sep;38(11):1257-78. [PMID: 18508057]